Serum amyloid A protein has been undervalued as a biomarker of COVID‐19

COVID-19 and diabetes: Knowledge in progress

(2020) Akhtar Hussain et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Diabetes is a risk factor for the progression and prognosis of COVID-19

(2020) Weina Guo et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis

(2020) Francisco Alejandro Lagunas-Rangel   JOURNAL OF MEDICAL VIROLOGY

Cytokine release syndrome in severe COVID-19

(2020) John B. Moore et al.   SCIENCE

On the Alert for Cytokine Storm: Immunopathology in COVID ‐19

(2020) Lauren A. Henderson et al.   Arthritis & Rheumatology

Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis

(2020) Huan Li et al.   JOURNAL OF INFECTION

Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation

(2019) Martin J. Page et al.   Scientific Reports

Serum Amyloid A Is an Exchangeable Apolipoprotein

(2018) Patricia G. Wilson et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections

(2016) Jeroen Slaats et al.   PLoS Pathogens

Serum amyloid A impairs the antiinflammatory properties of HDL

(2015) Chang Yeop Han et al.   JOURNAL OF CLINICAL INVESTIGATION

Association between serum amyloid A and obesity: a meta-analysis and systematic review

(2010) Yulan Zhao et al.   INFLAMMATION RESEARCH